JIC
ACGN

Johnson Investment Counsel’s Aceragen Inc ACGN Stock Holding History

Johnson Investment Counsel’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,478
Closed -$14.7K – 690
2022
Q4 		$14.7K Sell
2,478
-3
-0.1% -$18 ﹤0.01% 656
2022
Q3 		$16K Hold
2,481
– – ﹤0.01% 644
2022
Q2 		$19K Hold
2,481
– – ﹤0.01% 650
2022
Q1 		$21K Buy
+2,481
New +$22.4K ﹤0.01% 666

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Johnson Investment Counsel's ACGN Position: Q1 2023 in Review

Johnson Investment Counsel sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 2,478 shares — an estimated $14.7K sold.

Johnson Investment Counsel first reported a position in ACGN in Q1 2022 and held it in 4 quarters. The position peaked at $21K in Q1 2022. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.

  • Johnson Investment Counsel reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
  • Johnson Investment Counsel sold 2,478 Aceragen Inc shares in Q1 2023, an estimated $14.7K.
  • Johnson Investment Counsel first reported a position in Aceragen Inc in Q1 2022 and held it in 4 quarters.
  • Johnson Investment Counsel's Aceragen Inc position peaked at $21K in Q1 2022.
  • 19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.

Based on Johnson Investment Counsel's 13F filing for Q1 2023, filed 15 May 2023.